Related Experiment Video
Updated: Sep 16, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
Trends in Pediatric Blood Pressure-Lowering Prescription Fills During 2017-2023
Ashutosh Kumar1,2, Nicole L Therrien1, John Ogwuegbu1,3
1Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Insights
Pediatric blood pressure medication fills saw a slight overall increase from 2017-2023. This rise was primarily driven by a significant increase in fills among adolescent females, particularly for non-guideline medications.
Area of Science:
- Pediatric pharmacology and public health surveillance.
- Analysis of prescription drug utilization trends in adolescents.
Background:
- Lack of national data on blood pressure-lowering prescription trends in U.S. children and adolescents.
- Importance of monitoring medication use in the pediatric population for public health insights.
Purpose of the Study:
- To estimate national trends in blood pressure-lowering prescription fills among U.S. individuals aged 3-17 years.
- To analyze these trends by sex and age group.
- To examine fills for guideline-recommended versus non-guideline medications.
Main Methods:
- Utilized IQVIA's Total Patient Tracker database (covering 94% of U.S. outpatient retail fills) from 2017-2023.
- Analyzed prescription fills for 113 generic blood pressure-lowering medications across 21 drug classes.
- Employed Joinpoint regression to estimate average annual percentage change in fill rates.
Main Results:
- Overall blood pressure-lowering prescription fills in ages 3-17 increased slightly from 1.93% to 2.09% (2017-2023).
- Fills remained stable in males but increased significantly (23.9%) in females, particularly those aged 13-17 years (6.3% average annual increase).
- Prescription fills for guideline-recommended medications either stabilized or decreased, while increases were seen in non-guideline medications.
Conclusions:
- Blood pressure-lowering prescription fills are increasing in U.S. youth, with a notable rise in adolescent females.
- The increase is largely attributed to medications not listed in the 2017 American Academy of Pediatrics guideline.
- Findings suggest potential off-label prescribing or use for conditions beyond pediatric hypertension.
Introduction:
There are no national estimates for blood pressure-lowering prescription trends among the U.S. pediatric population. This study describes trends in blood pressure-lowering prescription fills among individuals aged 3-17 years by sex and age group.
Methods:
Data were obtained from IQVIA's Total Patient Tracker database covering 94% of all outpatient retail prescription fills in the U.S. The key outcome was blood pressure-lowering prescription fills during 2017-2023, utilizing a list of 113 generic medications from 21 drug classes. In addition, a subset of 20 medications recommended in the 2017 American Academy of Pediatrics guideline was examined. Annual population percentage and percentage change compared with 2017 were reported, and average annual percentage change was estimated using Joinpoint regression.
Results:
From 2017 to 2023, blood pressure-lowering prescription fills among those aged 3-17 years increased slightly from 1.93% (95% CI=1.88%, 1.98%) to 2.09% (95% CI=2.04%, 2.14%). Among males, blood pressure-lowering prescription fills remained stable (between 2.32% and 2.38%; average annual percentage change= -0.3%; p=0.545), whereas fills among females increased by 23.9% (from 1.49% to 1.84%; average annual percentage change=4.16%; p<0.001). The sharpest increase occurred among females aged 13-17 years (from 2.26% to 3.17%; average annual percentage change=6.3%; p<0.001). Prescription fills for guideline-recommended medications either remained stable or declined, with some variation by sex and age group.
Conclusions:
Results indicate growth in blood pressure-lowering prescription fills, especially among females aged 13-17 years. Increases were driven by medications not included in the 2017 American Academy of Pediatrics guideline, suggesting that blood pressure-lowering medications may be increasingly prescribed for conditions other than pediatric hypertension.
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Pre-Procedural Guidelines for Assessing Blood Pressure
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications

